Biostem Technologies (BSEM) Inventory Turnover Ratio, from second quarter 2026 to second quarter , current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
BioStem Technologies, Inc.  (Nasdaq: BSEM)
 

Biostem Technologies Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Biostem Technologies, Inc. inventory turnover ratio, the Biostem Technologies, Inc.'s ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 1.97 in the second quarter 2026, BSEM's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Biostem Technologies in Jun 30 2026 quarter, has decreased to 185 days, compare to 384 days, in the Jun 30 2025 quarter.

Within Healthcare sector BioStem Technologies, Inc. achieved the highest inventory turnover ratio. While inventory turnover ranking remained unchanged in the Second Quarter 2026 compared to previous quarter at no. .

BSEM Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Biostem Technologies, Inc. Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BSEM Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Jun 30 2025)
II. Quarter


Y / Y Inventory Growth - - - - -
Y / Y Cost of Sales Growth - - - - -
Inventory Turnover Ratio (TTM) 1.97 0.95 - - -
BSEM's Total Ranking # # # # #
Average inventory processing period 185 383 - - -
Seq. Inventory Growth 63.76 % - - - -
Seq. Cost of Sales Growth 346.39 % - - - -




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #

Inventory Turnover Ratio Statistics
High Average Low
0 0 0
 



BSEM Company Profile >> Back to BSEM Efficiency Comparisons >> Compare BSEM Inventory Turnover Ratio to its Competitors

Financial Statements
Biostem Technologies's Inventories $ 5 Millions Visit BSEM's Balance sheet
Biostem Technologies's Cost of Revenues TTM $ 4 Millions Visit BSEM's Income Statement
What are BSEM's Sales? Visit BSEM's Sales by Segment

Other Inventory Turnover Ratios
Biostem Technologies's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BSEM's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BSEM's Competitors
Inventory Turnover Ratio for BSEM's Suppliers
Inventory Turnover Ratio for BSEM's Customers

You may also want to know
BSEM's Sales Growth Rates BSEM's Pe Price to earnings ratio BSEM's Receivables Turnover Ratio BSEM's Stock Quote
BSEM's Net Income Growth Rates BSEM's Ps Price to Sales ratio BSEM's Sales per Employee BSEM's Asset Turnover Ratio
BSEM's Net Margin BSEM's Pb Price to Book ratio BSEM's Financial Strength Ratios BSEM's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Avita Medical Inc   2.18 $ 13.950  Millions$ 6  Millions
Johnson and Johnson  2.17 $ 31,428.000  Millions$ 14,516  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  2.15 $ 14.508  Millions$ 7  Millions
Orthofix Medical Inc   2.15 $ 240.218  Millions$ 112  Millions
Icu Medical Inc  2.15 $ 1,314.853  Millions$ 613  Millions
Anika Therapeutics Inc   2.14 $ 46.366  Millions$ 22  Millions
Amphastar Pharmaceuticals Inc   2.14 $ 381.911  Millions$ 178  Millions
Bioventus Inc   2.14 $ 182.542  Millions$ 85  Millions
Dariohealth Corp   2.10 $ 8.985  Millions$ 4  Millions
Bio techne Corp  2.10 $ 414.798  Millions$ 197  Millions
Yunhong Green Cti Ltd   2.09 $ 17.362  Millions$ 8  Millions
Aytu Biopharma Inc  2.09 $ 18.697  Millions$ 9  Millions
Repligen Corp  2.08 $ 362.434  Millions$ 174  Millions
Anteris Technologies Global Corp   2.08 $ 0.561  Millions$ 0  Millions
Lifevantage Corp  2.08 $ 39.334  Millions$ 19  Millions
Boston Scientific Corporation  2.07 $ 6,315.000  Millions$ 3,054  Millions
Organon and Co   2.06 $ 2,899.000  Millions$ 1,405  Millions
Glaukos Corp  2.06 $ 128.016  Millions$ 62  Millions
Orasure Technologies Inc  2.05 $ 64.117  Millions$ 31  Millions
Zomedica Corp   2.05 $ 11.772  Millions$ 6  Millions
Standard Biotools Inc   2.02 $ 40.982  Millions$ 20  Millions
Phibro Animal Health Corporation  2.02 $ 1,004.346  Millions$ 498  Millions
Waters Corporation  2.00 $ 2,008.498  Millions$ 1,005  Millions
Clearpoint Neuro Inc   1.96 $ 15.809  Millions$ 8  Millions
Skinhealth Systems Inc   1.95 $ 96.775  Millions$ 50  Millions
Retractable Technologies Inc  1.94 $ 33.979  Millions$ 17  Millions
Intuitive Surgical Inc   1.94 $ 3,676.900  Millions$ 1,899  Millions
Lifeloc Technologies Inc   1.93 $ 5.381  Millions$ 3  Millions
Accuray Incorporated  1.93 $ 290.064  Millions$ 150  Millions
Nature s Sunshine Products inc   1.92 $ 131.811  Millions$ 69  Millions

Date modified: 2026-10-24T05:30:52+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.